Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?
Vozella F, Latagliata R, Carmosino I, Volpicelli P, Montagna C, Romano A, Roberto A, Finsinger P, Mancini M, Breccia M, Oliva E, Oliva E. Vozella F, et al. Among authors: finsinger p. Hematol Oncol. 2015 Mar;33(1):48-51. doi: 10.1002/hon.2134. Epub 2014 Feb 18. Hematol Oncol. 2015. PMID: 25950027
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
Finsinger P, Breccia M, Minotti C, Carmosino I, Girmenia C, Chisini M, Volpicelli P, Vozella F, Romano A, Montagna C, Colafigli G, Cimino G, Avvisati G, Petti MC, Lo-Coco F, Foà R, Latagliata R. Finsinger P, et al. Ann Hematol. 2015 Feb;94(2):195-200. doi: 10.1007/s00277-014-2197-7. Epub 2014 Sep 4. Ann Hematol. 2015. PMID: 25186786
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
Latagliata R, Volpicelli P, Breccia M, Vozella F, Romano A, Montagna C, Molica M, Finsinger P, Carmosino I, Serrao A, Zacheo I, Santopietro M, Salaroli A, Alimena G. Latagliata R, et al. Among authors: finsinger p. Am J Hematol. 2015 Feb;90(2):105-8. doi: 10.1002/ajh.23879. Epub 2014 Nov 19. Am J Hematol. 2015. PMID: 25349084 Free article.
Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemia.
Latagliata R, Isidori A, Breccia M, Carmosino I, Vozella F, Volpicelli P, Finsinger P, Barulli S, Loglisci G, Santopietro M, Federico V, Diverio D, Nanni M, Mancini M, Visani G, Alimena G. Latagliata R, et al. Among authors: finsinger p. Acta Haematol. 2013;129(2):126-34. doi: 10.1159/000343384. Epub 2012 Nov 28. Acta Haematol. 2013. PMID: 23207803 Free article.
Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response.
Breccia M, Loglisci G, Cannella L, Finsinger P, Mancini M, Serrao A, Santopietro M, Salaroli A, Alimena G. Breccia M, et al. Among authors: finsinger p. Leuk Lymphoma. 2012 May;53(5):985-6. doi: 10.3109/10428194.2011.643408. Epub 2012 Jan 11. Leuk Lymphoma. 2012. PMID: 22112007 No abstract available.
22 results